Regulatory & Reimbursement
The Digest: April 2025
In this month's news, a flurry of 510(k) clearances (and one De Novo) and major M&A plays by Viscogliosi Brothers, Zydus Lifesciences, and more.
Read ArticleColin Miller
Contributing Writer
5 Years of Experience
About
Colin Miller is a staff writer and medtech analyst. Colin focuses on emerging and disruptive medical device technologies within vast therapeutic areas such as women’s health, wound care, neurovascular, critical care, surgical robotics and cardiovascular. Colin attended McGill University in Montreal and graduated from the University of Minnesota.